COMPANY
InSitu Biologics
Funding and NIH signals
- SEC Form D raise Raised $1.25M in debt securities (Form D filed Aug 10, 2026; amended Oct 14, 2026); +1 other Form D filing in the last 12 months. SEC Form D 0001723443-26-000005 (Aug 10, 2026)
Evidence (2 events)
- Aug 10, 2026 · SEC Form D 0001723443-26-000005
Name of Issuer: InSitu Biologics, Inc.; CIK: 1723443; Address: Oakdale, MN; Submission type: D; Filing date: 2026-08-10; Industry Group: Biotechnology; Date of First Sale: 2026-08-04; Types of Securities Offered: Debt, Other (Convertible Promissory Note); Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 1250000; Federal exemptions: 06b || Name of Issuer: InSitu Biologics, Inc.; CIK: 1723443; Address: Oakdale, MN; Submission type: D/A; Filing date: 2026-10-14; Industry Group: Biotechnology; Date of First Sale: 2026-08-04; Types of Securities Offered: Debt, Option/warrant, Other (Convertible Promissory Note); Business combination transaction: false; Total Offering Amount: 3375000; Total Amount Sold: 1250000; Federal exemptions: 06b - Dec 18, 2025 · SEC Form D 0001723443-25-000003
Name of Issuer: InSitu Biologics, Inc; CIK: 1723443; Address: Oakdale, MN; Submission type: D; Filing date: 2025-12-18; Industry Group: Biotechnology; Date of First Sale: 2025-11-13; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 8000000; Total Amount Sold: 3950000; Federal exemptions: 06b
- Aug 10, 2026 · SEC Form D 0001723443-26-000005